Opinion

Video

Tisotumab Vedotin for Patients With Cervical Cancer

Author(s):

Claire Friedman, MD,Emily Davan, RN

Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Related Content
The FDA granted breakthrough device designation to an MRD test for patients with stage 2 colorectal cancer: © stock.adobe.com.
September 17th 2025

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

Alex Biese
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
September 17th 2025

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
Long-term follow-up data from the phase 3 MANIFEST 2 clinical trial have been revealed: © stock.adobe.com
September 17th 2025

Pelabresib Plus Jakafi Elicits Meaningful Responses in Myelofibrosis

Alex Biese
Kate Weissman, a gynecologic cancer survivor
September 17th 2025

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Breyanzi demonstrated a 95.5% response rate among in relapsed/refractory marginal zone lymphoma: © stock.adobe.com.
September 17th 2025

Breyanzi Shows Durable Responses in R/R Marginal Zone Lymphoma

Spencer Feldman
Biomarker testing is vital for all patients with lung cancer: © stock.adobe.com.
September 17th 2025

Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

Spencer Feldman